Bryn Mawr Capital Management LLC Raises Stake in The Clorox Company (NYSE:CLX)

Bryn Mawr Capital Management LLC boosted its holdings in shares of The Clorox Company (NYSE:CLX) by 19.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,455 shares of the company’s stock after buying an additional 718 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Clorox were worth $635,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of CLX. Fortitude Family Office LLC purchased a new position in shares of Clorox during the 4th quarter valued at approximately $29,000. Tyler Stone Wealth Management increased its holdings in Clorox by 64.5% in the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock valued at $33,000 after buying an additional 100 shares in the last quarter. Hartford Financial Management Inc. raised its position in shares of Clorox by 57.1% in the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock worth $37,000 after acquiring an additional 93 shares during the period. Valley National Advisers Inc. boosted its stake in shares of Clorox by 458.3% during the 4th quarter. Valley National Advisers Inc. now owns 268 shares of the company’s stock worth $38,000 after acquiring an additional 220 shares in the last quarter. Finally, BKM Wealth Management LLC purchased a new stake in shares of Clorox during the 4th quarter worth about $41,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Down 0.7 %

Shares of NYSE CLX opened at $146.48 on Friday. The stock has a market cap of $18.18 billion, a PE ratio of 232.51, a P/E/G ratio of 2.32 and a beta of 0.43. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $178.21. The company has a 50-day moving average of $149.39 and a 200 day moving average of $142.60.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the previous year, the firm posted $0.98 EPS. The business’s revenue for the quarter was up 16.0% compared to the same quarter last year. As a group, sell-side analysts predict that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.28%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is presently 761.92%.

Wall Street Analyst Weigh In

CLX has been the subject of a number of analyst reports. Morgan Stanley reaffirmed an “equal weight” rating and issued a $160.00 price target on shares of Clorox in a report on Tuesday, March 26th. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price for the company in a research note on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research note on Wednesday, April 17th. Citigroup reduced their price objective on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a research report on Tuesday, April 16th. Finally, The Goldman Sachs Group began coverage on shares of Clorox in a report on Friday, March 1st. They set a “sell” rating and a $140.00 price objective on the stock. Four analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.